NCT06898775View on ClinicalTrials.gov

Passive Safety Surveillance Data of Dengue Vaccine, Qdenga (TAK 003) in Private Vaccination Sites in Buenos Aires, Argentina.

Active, not recruitingOBSERVATIONAL

Enrollment

112,345

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

December 15, 2024

Study Completion Date

June 1, 2025

Conditions

Dengue Vaccines

Trial Locations (1)

Unknown

Fundación Vacunar, Buenos Aires

All Listed Sponsors

lead

Fundación Vacunar

OTHER